CisplatinAntineoplastic Combined Chemotherapy ProtocolsDeoxycytidineMetoclopramideOndansetronVomitingAntineoplastic AgentsChemotherapy, AdjuvantDiphenhydramineAntiemeticsAntimetabolites, AntineoplasticNauseaCombined Modality TherapyDrug Administration ScheduleTreatment OutcomeEtoposidePaclitaxelGranisetronDisease-Free SurvivalTesticular NeoplasmsNeoplasms, Germ Cell and EmbryonalNeoplasm StagingPancreatic NeoplasmsSurvival RateSurvival AnalysisLung NeoplasmsCarcinoma, Squamous CellDrug Resistance, NeoplasmVinblastineDoxorubicinCarboplatinCarcinoma, Non-Small-Cell LungTaxoidsDeoxycytidine KinaseCyclophosphamideInfusions, IntravenousAdenocarcinomaCell Line, TumorNeoadjuvant TherapyPlatinumNeutropeniaDose-Response Relationship, DrugOvarian NeoplasmsBiliary Tract NeoplasmsIfosfamidePrognosisBreast NeoplasmsNeoplasmsDrug SynergismNeoplasm Recurrence, LocalOrganoplatinum CompoundsLeukopeniaNeoplasm MetastasisMaximum Tolerated DoseFluorouracilCamptothecinInduction ChemotherapyMethotrexateSalvage TherapyAntineoplastic Agents, PhytogenicApoptosisThrombocytopeniaTegafurDrug Screening Assays, AntitumorBleomycinXenograft Model Antitumor AssaysOxonic AcidUrologic NeoplasmsMice, NudeTime FactorsKaplan-Meier EstimateEquilibrative Nucleoside Transporter 1Head and Neck NeoplasmsDisease ProgressionCarcinoma, Transitional CellMitomycinFollow-Up StudiesRadiation-Sensitizing AgentsAnthracyclinesCarcinomaAntineoplastic Agents, AlkylatingCytarabineUrinary Bladder NeoplasmsRadiotherapy, AdjuvantTumor Cells, CulturedGuaninePlatinum CompoundsPeritoneal NeoplasmsCell SurvivalCarcinoma, Pancreatic DuctalAntibodies, Monoclonal, HumanizedVindesineClinical Trials as TopicMesotheliomaGerminomaHematologic DiseasesOsteosarcomaPleural NeoplasmsCA-19-9 AntigenInfusions, Intra-Arterial